Member Info for B2HS2L

Paulorufus
1 The second largest market is Germany according to a recent RNS.

2 "We have seen no substantial orders aside from the initial panic order from the pandemic start"
We were recently updated that we are now selling to 130 countries, an increase of 30% from the 100 countries we knew about.
How do you know please, that none of these 30 countries have provided a 'substantial' order?

3 Agree with gggg21 comments re further UK orders, as 288,000 per week isn't going to be enough shortly.

Hi banjowest, - Could you sort out the spelling of my handle on your list please, - B2HS2L, not B2HSS2L. Tah.
Some Mole Catching Algorithm you got there.

"Similarly with airlines - if everyone took the test at the check in (in all countries) then you would know that everyone on the plane is virus free with no need for social distancing."

Airport authorities will insist that nobody is getting anywhere near a check in desk until they have been POC tested in the car park. No-one is entering a terminal unless POC is negative.

AshTrey
Solution: Here's a test that DOES NOT REQUIRE THIS REAGENT, - At no extra cost or inconvenience to yourself.

Result: OK, cool, I'll be ordering more soon.

They arn't sales until the money is in the bank.
NCYT operates on a payment with order basis.

"Novacyt is also pleased with the progress it is making in the US market and expects to update the market in due course."
- I don't think the company would insert this comment into an RNS, if there were no sales to report.

There are going to be some very sorry peaved people soon, when they sell today and read the USA sales figures published shortly.
SP takes a hit today, but watch NCYT score on the rebound..

" with the top two countries being the UK and Germany."
What that aren't saying is that USA is third!!!

"Novacyt is now selling its COVID-19 test into more than 130 countries, with the top two countries being the UK and Germany. Novacyt is also pleased with the progress it is making in the US market and expects to update the market in due course."

Germany was a surprise for me, - it hasn't featured much in previous communications.
130 country count now, that's 30% up on the previous count, so I'm assuming many small orders, (with those small orders repeated as second spike approaches).

The comment about USA sales yet to come (hopefully this week) is the one we should be paying most attention to I suspect.

If the LFD works as per the side of the tin, govt. will have to legislate for the asymptomatic.
If proven to have Covid-19, they will need to have their immediate future advised asap, - no arguments.

You mean... inventing the cat flap because he was sure he'd got gravity off to a tee...

Guys,
rt-q-PCR test kits contain 96 tests per kit.
A larger size of test kit is being developed and contains 1536 tests, as per recent RNS.

Acuere, - Not to mention sales performance from USA.
May as well not have a US partner for all the info we have been given.

RNS Mon, 30th Mar 2020 07:07

Graham Mullis, Chief Executive Officer of Novacyt, commented:

"We continue to report unprecedented demand for our COVID-19 test as the rate of growth in orders increases each week and continues to exceed our expectations. As a result, and despite our best efforts to ensure we are fully prepared to meet demand, the rate of sales growth is beginning to be restricted by our ability to scale-up manufacturing as quickly as we would like. This, therefore, remains an immediate priority for the Company and it is our objective to make as many tests available to as many clinicians around the world as quickly as possible. We are very pleased with how our manufacturing partners, BioType and Yourgene, are supporting Novacyt during this time and we continue to evaluate additional capacity enhancing options to address the global demand for our COVID-19 test. Again, I would like to thank all of our employees and suppliers for their ongoing hard work and support during this pandemic."

++++
'the rate of sales growth is beginning to be restricted by our ability to scale-up manufacturing as quickly as we would like'.
Now that the NCYT marketing team is going into overdrive, I think we can say manufacturing capacity issues are solved now that EM Analytical are ramping up production.

I would not be surprised if test kit production capacity has been increased further due to the success of the dPCR test kit, which costs less to produce and takes less time to manufacture.

I await an update on test kit production capacity, and confirmation of the involvement of EM Analytical in test kit production in the next RNS, - possibly Monday.

Correction, - well done LoLo and Wilson!

Note the below transcript is incomplete, but the link enables access to document.
Well done LoLo

EM Analytical certified by LR in just 20 days.
26 May 2020
UK laboratory testing facility transforms business and secures ISO 9001 and ISO 13485 certification from Lloyd’s Register (LR) to manufacture COVID-19 testing kits.

Share this news item
UK laboratory EM Analytical (EMA) has won a contract to manufacture millions of UK and WHO approved COVID-19 tests after securing certification to ISO 9001 (quality) and ISO 13485 (medical device) standards in just 20 days.

The contract with international diagnostics group, Novacyt, came at the right time. With serious cash flow issues after losing customers due to the pandemic, EMA needed a boost.

EMA Managing Director Daniel Royston said: “We had to win that work to save the business. We’re an interdisciplinary science lab providing equipment for universities, start-ups and SMEs R&D projects. New product development is just not happening for these organisations at the moment and we were very close to having serious financial issues if this was to go on for months on end.

“Once we were offered the contract, I took a £250K bank loan and re-mortgaged the house to pay for the additional instrumentation we needed. We repurposed the lab, making sure we could meet social distancing requirements. Using social media, I quadrupled the workforce in a week, recruiting lab technicians and diagnostics experts who had been made redundant or needed jobs and trained them online. We work to the rule ‘safety first, production second’ – everyone works in their own bay, they have full PPE and we have our team meetings in the field opposite for staff meetings!”

At the same time, Daniel contacted Lloyd’s Register (LR) to see if certification - a process which usually takes around three months – could be done within three weeks.

“LR said they could help – and they did. The medical team at LR were able to turnaround the contracts and design an initial audit plan in a very short timeframe. A lot of the audit was done remotely via Skype for Business. Sharing documents, video calls from home offices – it was certainly different, but it worked perfectly. Walk through video audits using a mobile phone meant the auditor could see evidence of our PAT testing, asset procedures and everything else they needed to complete the certification audit.

“The paper work requirements were immense. It was difficult – but nothing compared to setting up a lab in six days! Getting it over the line though is a huge credit to our team and LR. Without LR, we couldn’t have made the kits – and we couldn’t have helped save lives. It’s as simple as that.”

LR Medical Assessor Kenny McKeegan commented: “The primary objective of the ISO 13485 certification process is to ensure medical devices consistently meet customer needs and applicable regulatory requirements while ISO 9001 is all about demonstrating a commitment to quality through continual improvement.
https://www.lr.org/en-gb/latest-news/0526-em-analytical-certified-by-lr-

"it’s not passed through much of the population and there are still plenty people infected."

- and we don't know much about how long it takes for 'those who've had it' to lose any natural immunity developed after previous infection.

All to play for come winter.

Well done Parkez.
Where did you find the answer, so I'll know where to start looking when future French Bourse questions arrive.

Interferon-ß is a naturally occurring substance the body produces as part of the reaction to infection.
As such, we are augmenting levels of interferon, and IMO an Interferon-ß boost is most likely to be efficacious, -
unless you can overdose of course.